首页 > 最新文献

Acta microbiologica et immunologica Hungarica最新文献

英文 中文
T2Bacteria panel used simultaneously with blood cultures helps to determine the etiology of bloodstream infections. T2Bacteria panel 与血液培养同时使用,有助于确定血流感染的病因。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-11-19 DOI: 10.1556/030.2024.02417
Mislav Peras, Tomislav Kuliš, Ivana Mareković

Bloodstream infections (BSI) result in significant morbidity and mortality rates, and delayed administration of appropriate antimicrobial treatment is a major predictor of poor outcomes. T2 magnetic resonance (T2MR®) (T2 Biosystems®, Lexington, MA, USA) is an innovative technology that can rapidly identify pathogens from a sample of whole blood in a remarkably short time frame of 3-5 h. We are evaluating if the T2Bacteria Panel (T2BP) contributes to the etiological diagnosis of bloodstream infections when combined with standard blood cultures (BC). The study was performed between December 2018 and March 2019, and a total of 28 patients with suspected BSI were included. The most notable finding of our study was that the addition of T2BP to BC in a diagnostic workflow led to a statistically significant higher rate of T2BP-targeted bacteria identification in patients with suspected BSI (46.4% versus 7.1%, P = 0.001) when compared to BC alone. Considering the measures of diagnostic accuracy, T2BP showed 100.00% sensitivity, 88.24% specificity, 100% negative predictive value (NPV), and 84.62% positive predictive value (PPV). Our findings give valuable insights for microbiologists and clinicians into this molecular method and its advantages in routine diagnostics of BSI.

血流感染 (BSI) 会导致严重的发病率和死亡率,而延迟给予适当的抗菌治疗是导致不良后果的一个主要因素。T2磁共振(T2MR®)(T2 Biosystems®,美国马萨诸塞州列克星敦)是一项创新技术,能在3-5小时的极短时间内从全血样本中快速鉴定病原体。我们正在评估T2Bacteria Panel(T2BP)与标准血液培养(BC)相结合是否有助于血流感染的病原学诊断。研究在 2018 年 12 月至 2019 年 3 月期间进行,共纳入 28 例疑似 BSI 患者。我们的研究最显著的发现是,在诊断工作流程中将 T2BP 添加到 BC 中,与单独使用 BC 相比,疑似 BSI 患者的 T2BP 靶向细菌鉴定率明显更高(46.4% 对 7.1%,P = 0.001)。就诊断准确性而言,T2BP 的敏感性为 100.00%,特异性为 88.24%,阴性预测值 (NPV) 为 100%,阳性预测值 (PPV) 为 84.62%。我们的研究结果为微生物学家和临床医生了解这种分子方法及其在 BSI 常规诊断中的优势提供了宝贵的信息。
{"title":"T2Bacteria panel used simultaneously with blood cultures helps to determine the etiology of bloodstream infections.","authors":"Mislav Peras, Tomislav Kuliš, Ivana Mareković","doi":"10.1556/030.2024.02417","DOIUrl":"10.1556/030.2024.02417","url":null,"abstract":"<p><p>Bloodstream infections (BSI) result in significant morbidity and mortality rates, and delayed administration of appropriate antimicrobial treatment is a major predictor of poor outcomes. T2 magnetic resonance (T2MR®) (T2 Biosystems®, Lexington, MA, USA) is an innovative technology that can rapidly identify pathogens from a sample of whole blood in a remarkably short time frame of 3-5 h. We are evaluating if the T2Bacteria Panel (T2BP) contributes to the etiological diagnosis of bloodstream infections when combined with standard blood cultures (BC). The study was performed between December 2018 and March 2019, and a total of 28 patients with suspected BSI were included. The most notable finding of our study was that the addition of T2BP to BC in a diagnostic workflow led to a statistically significant higher rate of T2BP-targeted bacteria identification in patients with suspected BSI (46.4% versus 7.1%, P = 0.001) when compared to BC alone. Considering the measures of diagnostic accuracy, T2BP showed 100.00% sensitivity, 88.24% specificity, 100% negative predictive value (NPV), and 84.62% positive predictive value (PPV). Our findings give valuable insights for microbiologists and clinicians into this molecular method and its advantages in routine diagnostics of BSI.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of Clostridioides difficile PCR ribotype 181 after the COVID-19 pandemic in Northern Greece. 希腊北部 COVID-19 大流行后艰难梭菌 PCR 核型 181 的流行病学。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-10-28 DOI: 10.1556/030.2024.02401
Eliana Charisi, Katerina Tsioka, Theodoros Karampatakis, Melina Kachrimanidou

Clostridioides difficile infection (CDI) is one of the most significant causes of diarrhea in hospitalized patients. The aim of this study was to investigate the incidence and epidemiology of CDI after the COVID-19 pandemic in hospitalized patients in a rehabilitation center in Thessaloniki, Greece. Α retrospective observational cohort study was performed in inpatients diagnosed with diarrhea of all ages (January 2023 - December 2023) who were initially screened for CDI. From the total cohort of patients with proven CDI, some patients were randomly selected based on their monthly isolation incidence throughout the study period, to investigate their epidemiological data and clinical characteristics. Laboratory diagnosis of CDI was performed by enzyme immunoassay, followed by specific anaerobic culture and molecular testing for detection of toxigenic C. difficile. The isolated C. difficile strains were further characterized by PCR ribotyping. The annual incidence of CDI during the study period was 27.1% (130/480). The linear trend of CDI incidence decreased from 32.5% to 18.2% (P = 0.024). The all-cause mortality rate was 5.0% (3/60). A positive correlation was observed between the length of hospital stay and the number of recurrences (r = 0.546, P < 0.001), while 28 patients (46.7%) experienced recurrence of the infection. Seven different PCR ribotypes were identified in this study. C. difficile tcdA+, tcdB+, cdtA+, cdtB+ PCR ribotype 181 (RT181) was the predominant (76.6%, 46/60), followed by toxin A-negative PCR RT017 (11.6%, 7/60). The annual incidence of CDI decreased after the COVID-19 pandemic. Our study demonstrates predominance of C. difficile RT181 with tcdA+, tcdB+, cdtA+, cdtB+ toxin gene profile after COVID-19 pandemic in Northern Greece.

艰难梭菌感染(CDI)是导致住院病人腹泻的最主要原因之一。本研究旨在调查希腊塞萨洛尼基一家康复中心的住院病人在 COVID-19 大流行后 CDI 的发病率和流行病学。该研究对所有年龄段(2023 年 1 月至 2023 年 12 月)确诊为腹泻的住院病人进行了回顾性观察队列研究,并对他们进行了 CDI 初步筛查。在所有已确诊的 CDI 患者中,根据其在整个研究期间的月隔离发病率随机抽取部分患者,以调查其流行病学数据和临床特征。CDI 的实验室诊断采用酶免疫测定法,然后进行特异性厌氧培养和分子检测,以检测致毒艰难梭菌。分离出的艰难梭菌菌株通过 PCR 核糖分型技术进一步鉴定。研究期间,艰难梭菌感染的年发病率为 27.1%(130/480)。CDI 发病率呈线性下降趋势,从 32.5% 降至 18.2%(P = 0.024)。全因死亡率为 5.0%(3/60)。住院时间与复发次数呈正相关(r = 0.546,P < 0.001),28 名患者(46.7%)出现感染复发。本研究发现了七种不同的 PCR 核型。以艰难梭菌 tcdA+, tcdB+, cdtA+, cdtB+ PCR 核型 181(RT181)为主(76.6%,46/60),其次是毒素 A 阴性 PCR RT017(11.6%,7/60)。COVID-19 大流行后,CDI 的年发病率有所下降。我们的研究表明,在希腊北部 COVID-19 大流行后,具有 tcdA+、ttcdB+、cttA+、cttB+ 毒素基因图谱的艰难梭菌 RT181 占主导地位。
{"title":"Epidemiology of Clostridioides difficile PCR ribotype 181 after the COVID-19 pandemic in Northern Greece.","authors":"Eliana Charisi, Katerina Tsioka, Theodoros Karampatakis, Melina Kachrimanidou","doi":"10.1556/030.2024.02401","DOIUrl":"https://doi.org/10.1556/030.2024.02401","url":null,"abstract":"<p><p>Clostridioides difficile infection (CDI) is one of the most significant causes of diarrhea in hospitalized patients. The aim of this study was to investigate the incidence and epidemiology of CDI after the COVID-19 pandemic in hospitalized patients in a rehabilitation center in Thessaloniki, Greece. Α retrospective observational cohort study was performed in inpatients diagnosed with diarrhea of all ages (January 2023 - December 2023) who were initially screened for CDI. From the total cohort of patients with proven CDI, some patients were randomly selected based on their monthly isolation incidence throughout the study period, to investigate their epidemiological data and clinical characteristics. Laboratory diagnosis of CDI was performed by enzyme immunoassay, followed by specific anaerobic culture and molecular testing for detection of toxigenic C. difficile. The isolated C. difficile strains were further characterized by PCR ribotyping. The annual incidence of CDI during the study period was 27.1% (130/480). The linear trend of CDI incidence decreased from 32.5% to 18.2% (P = 0.024). The all-cause mortality rate was 5.0% (3/60). A positive correlation was observed between the length of hospital stay and the number of recurrences (r = 0.546, P < 0.001), while 28 patients (46.7%) experienced recurrence of the infection. Seven different PCR ribotypes were identified in this study. C. difficile tcdA+, tcdB+, cdtA+, cdtB+ PCR ribotype 181 (RT181) was the predominant (76.6%, 46/60), followed by toxin A-negative PCR RT017 (11.6%, 7/60). The annual incidence of CDI decreased after the COVID-19 pandemic. Our study demonstrates predominance of C. difficile RT181 with tcdA+, tcdB+, cdtA+, cdtB+ toxin gene profile after COVID-19 pandemic in Northern Greece.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142520675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HCV genotype distribution in Istanbul: A detailed 7 year epidemiological overview and impact of Covid-19 pandemic. 伊斯坦布尔的 HCV 基因型分布:7 年流行病学详细概述及 Covid-19 大流行的影响。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-10-21 DOI: 10.1556/030.2024.02388
Begüm Nalça Erdin, Yüksel Akkaya, Arzu İrvem

Hepatitis C virus (HCV) is a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma worldwide. HCV has 8 genotypes (GT) and 86 subtypes and distribution of GTs varies based on geographical regions, transmission routes and even in cultural groups. The determination of viral genotype is crucial in choosing antiviral treatment, determining the duration of therapy, and monitoring treatment respose. Since 2014, with the usage of direct-acting antiviral agents (DAAs) in the treatment of HCV infections, a cure rate over 95% could be possible. Epidemiological data are important to combat a chronic HCV infections. Due to its geographical location, Turkey is like a bridge connecting Asia and Europe. Istanbul is the biggest and most crowded city of Turkey and has received immigration from many different countries, especially from Syria, in recent years and immigration still goes on. In addition, the COVID-19 pandemic has had devastating effects in our country. In this study, we determined the HCV genotypes in Health Sciences University Ümraniye Training and Research Hospital, in Istanbul between 2016 and 2022. Of the 322 patients analyzed during this 7-year period, HCV GT1b was the most prevalent GT in 65.2%, followed by GT3 in 15.5%, GT1a in 10.6%. Our data serve as a great mirror for HCV epidemiology in Turkey and contribute to global data.

丙型肝炎病毒(HCV)是全球慢性肝病、肝硬化和肝细胞癌的主要病因。丙型肝炎病毒(HCV)有 8 种基因型(GT)和 86 种亚型,GT 的分布因地理区域、传播途径甚至文化群体而异。确定病毒基因型对于选择抗病毒治疗、确定疗程和监测治疗反应至关重要。自 2014 年以来,随着直接作用抗病毒药物(DAAs)被用于治疗 HCV 感染,治愈率可超过 95%。流行病学数据对于防治慢性丙型肝炎病毒感染非常重要。由于其地理位置,土耳其就像一座连接亚洲和欧洲的桥梁。伊斯坦布尔是土耳其最大、最拥挤的城市,近年来接收了来自许多不同国家的移民,尤其是来自叙利亚的移民,而且移民仍在继续。此外,COVID-19 大流行病也对我国造成了破坏性影响。在这项研究中,我们确定了伊斯坦布尔健康科学大学于姆拉尼耶培训与研究医院在 2016 年至 2022 年期间的 HCV 基因型。在这 7 年间分析的 322 名患者中,HCV GT1b 是最常见的基因型,占 65.2%,其次是 GT3,占 15.5%,GT1a 占 10.6%。我们的数据为土耳其的HCV流行病学提供了一面很好的镜子,并为全球数据做出了贡献。
{"title":"HCV genotype distribution in Istanbul: A detailed 7 year epidemiological overview and impact of Covid-19 pandemic.","authors":"Begüm Nalça Erdin, Yüksel Akkaya, Arzu İrvem","doi":"10.1556/030.2024.02388","DOIUrl":"https://doi.org/10.1556/030.2024.02388","url":null,"abstract":"<p><p>Hepatitis C virus (HCV) is a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma worldwide. HCV has 8 genotypes (GT) and 86 subtypes and distribution of GTs varies based on geographical regions, transmission routes and even in cultural groups. The determination of viral genotype is crucial in choosing antiviral treatment, determining the duration of therapy, and monitoring treatment respose. Since 2014, with the usage of direct-acting antiviral agents (DAAs) in the treatment of HCV infections, a cure rate over 95% could be possible. Epidemiological data are important to combat a chronic HCV infections. Due to its geographical location, Turkey is like a bridge connecting Asia and Europe. Istanbul is the biggest and most crowded city of Turkey and has received immigration from many different countries, especially from Syria, in recent years and immigration still goes on. In addition, the COVID-19 pandemic has had devastating effects in our country. In this study, we determined the HCV genotypes in Health Sciences University Ümraniye Training and Research Hospital, in Istanbul between 2016 and 2022. Of the 322 patients analyzed during this 7-year period, HCV GT1b was the most prevalent GT in 65.2%, followed by GT3 in 15.5%, GT1a in 10.6%. Our data serve as a great mirror for HCV epidemiology in Turkey and contribute to global data.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of KPC-3 producing Escherichia coli ST410 in Volos, Greece. 在希腊沃洛斯检测到产 KPC-3 的大肠杆菌 ST410。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-09-17 DOI: 10.1556/030.2024.02376
Maria Chatzidimitriou,Pandora Tsolakidou,Maria Anna Kyriazidi,Stella Mitka
Escherichia coli A382 was isolated in July 2024 from a positive blood culture obtained from the central venous catheter of a male patient undergoing chemotherapy at the Hospital of Volos, Thessaly, Greece. Whole-genome sequencing analysis revealed that the isolate A382 is E. coli belonging to the ST410 high-risk clone, which co-harbors the blaKPC-3 and blaSHV-182 genes on an IncX3 plasmid. It also harbors blaTEM-1 and has five replicons, as follows: IncX3, IncQ1, CoIRNAI, IncF1A, and IncFIB. Complete genome analysis revealed that E. coli A382 isolate carries a range of virulence factors (iutA, iucC, fimH, fdeC, yehA, yehD, yehC, yehB, cgs, ahha, ccI, hlyE, papC, irp2, fyuA, lpfA, and nlpl) and many other non-beta-lactam resistance determinants, including dfrA14 and sul2, but it is susceptible to aminoglycosides, nitrofurantoin, tigecycline, colistin and ceftazidime-avibactam. In conclusion in this study, we describe the phenotypic and genome characteristics of an extensively drug-resistant E. coli ST410.
2024 年 7 月,希腊塞萨利沃洛斯医院从一名正在接受化疗的男性患者的中心静脉导管中获得的阳性血液培养物中分离出大肠埃希菌 A382。全基因组测序分析表明,分离物 A382 是属于 ST410 高风险克隆的大肠杆菌,在一个 IncX3 质粒上共同携带 blaKPC-3 和 blaSHV-182 基因。它还携带 blaTEM-1,并有以下五个复制子:IncX3、IncQ1、CoIRNAI、IncF1A 和 IncFIB。全基因组分析表明大肠杆菌 A382 分离物携带一系列毒力因子(iutA、iucC、fimH、fdeC、yehA、yehD、yehC、yehB、ccs、ahha、ccI、hlyE、papC、irp2、fyuA、lpfA、和 nlpl)以及许多其他非β-内酰胺耐药基因,包括 dfrA14 和 sul2,但它对氨基糖苷类、硝基呋喃妥因、替加环素、大肠杆菌素和头孢唑肟-阿维巴坦易感。总之,本研究描述了一种广泛耐药大肠杆菌 ST410 的表型和基因组特征。
{"title":"Detection of KPC-3 producing Escherichia coli ST410 in Volos, Greece.","authors":"Maria Chatzidimitriou,Pandora Tsolakidou,Maria Anna Kyriazidi,Stella Mitka","doi":"10.1556/030.2024.02376","DOIUrl":"https://doi.org/10.1556/030.2024.02376","url":null,"abstract":"Escherichia coli A382 was isolated in July 2024 from a positive blood culture obtained from the central venous catheter of a male patient undergoing chemotherapy at the Hospital of Volos, Thessaly, Greece. Whole-genome sequencing analysis revealed that the isolate A382 is E. coli belonging to the ST410 high-risk clone, which co-harbors the blaKPC-3 and blaSHV-182 genes on an IncX3 plasmid. It also harbors blaTEM-1 and has five replicons, as follows: IncX3, IncQ1, CoIRNAI, IncF1A, and IncFIB. Complete genome analysis revealed that E. coli A382 isolate carries a range of virulence factors (iutA, iucC, fimH, fdeC, yehA, yehD, yehC, yehB, cgs, ahha, ccI, hlyE, papC, irp2, fyuA, lpfA, and nlpl) and many other non-beta-lactam resistance determinants, including dfrA14 and sul2, but it is susceptible to aminoglycosides, nitrofurantoin, tigecycline, colistin and ceftazidime-avibactam. In conclusion in this study, we describe the phenotypic and genome characteristics of an extensively drug-resistant E. coli ST410.","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":"23 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142263750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic resistant Escherichia coli strains in healthy pets from Tamaulipas, Mexico. 墨西哥塔毛利帕斯州健康宠物中的抗生素耐药大肠杆菌菌株。
IF 1.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-09-12 DOI: 10.1556/030.2024.02340
José Antonio Mandujano-Hernández,José Vázquez-Villanueva,Erick de Jesús De Luna-Santillana,Gildardo Rivera,Virgilio Bocanegra-García,Ana Verónica Martínez-Vázquez
Antibiotic resistance constitutes a significant public health challenge, with diverse reservoirs of resistant bacteria playing pivotal roles in their dissemination. Among these reservoirs, pets are carrying antibiotic-resistant strains. The objective of this study was to assess the resistance profiles of Escherichia coli, and the prevalence of extended-spectrum β-lactamase (ESBL) producing E. coli strains in dogs and cats from Tamaulipas, Mexico. A total of 300 stool samples (150 dogs and 150 cats) from healthy pets were subjected to analysis. Antibiotic susceptibility testing and the identification of ESBLs were carried out by disc diffusion method. The presence of resistance genes, class 1, 2, and 3 integrons (intI1, intI2, and intI3) and phylogroups was determined by PCR analysis. The findings reveal that 42.6% (128/300) of the strains exhibited resistance to at least one of the eight antibiotics assessed, and 18.6% (56/300) demonstrated multidrug resistance (MDR), that distributed across 69 distinct resistance patterns. Altogether 2.6% of E. coli strains (8/300) were confirmed as TEM and CTX-M type ESBL producers. These outcomes underscore the roles of dogs and cats in Tamaulipas as reservoirs for the dissemination of MDR and/or ESBL strains. The results underscore the necessity for conducting prevalence studies on ESBL-producing E. coli, forming a foundation for comprehending the present scenario and formulating strategies for the control and mitigation of this issue.
抗生素耐药性是一项重大的公共卫生挑战,各种耐药性细菌库在其传播过程中发挥着关键作用。在这些蓄水池中,宠物携带着抗生素耐药菌株。本研究旨在评估墨西哥塔毛利帕斯州猫狗中大肠埃希菌的耐药性概况以及产生广谱β-内酰胺酶(ESBL)的大肠埃希菌菌株的流行情况。共对 300 份健康宠物的粪便样本(150 份狗样本和 150 份猫样本)进行了分析。抗生素敏感性测试和 ESBLs 的鉴定是通过盘扩散法进行的。耐药性基因、1、2 和 3 类整合子(intI1、intI2 和 intI3)以及系统群的存在情况则通过 PCR 分析来确定。研究结果显示,42.6%(128/300)的菌株对所评估的八种抗生素中的至少一种表现出耐药性,18.6%(56/300)的菌株表现出多药耐药性(MDR),分布在 69 种不同的耐药性模式中。共有 2.6% 的大肠杆菌菌株(8/300)被确认为 TEM 和 CTX-M 型 ESBL 生产者。这些结果表明,在塔毛利帕斯州,猫狗是 MDR 和/或 ESBL 菌株传播的 "蓄水池"。这些结果表明,有必要对产 ESBL 大肠杆菌进行流行率研究,从而为了解目前的情况以及制定控制和缓解这一问题的策略奠定基础。
{"title":"Antibiotic resistant Escherichia coli strains in healthy pets from Tamaulipas, Mexico.","authors":"José Antonio Mandujano-Hernández,José Vázquez-Villanueva,Erick de Jesús De Luna-Santillana,Gildardo Rivera,Virgilio Bocanegra-García,Ana Verónica Martínez-Vázquez","doi":"10.1556/030.2024.02340","DOIUrl":"https://doi.org/10.1556/030.2024.02340","url":null,"abstract":"Antibiotic resistance constitutes a significant public health challenge, with diverse reservoirs of resistant bacteria playing pivotal roles in their dissemination. Among these reservoirs, pets are carrying antibiotic-resistant strains. The objective of this study was to assess the resistance profiles of Escherichia coli, and the prevalence of extended-spectrum β-lactamase (ESBL) producing E. coli strains in dogs and cats from Tamaulipas, Mexico. A total of 300 stool samples (150 dogs and 150 cats) from healthy pets were subjected to analysis. Antibiotic susceptibility testing and the identification of ESBLs were carried out by disc diffusion method. The presence of resistance genes, class 1, 2, and 3 integrons (intI1, intI2, and intI3) and phylogroups was determined by PCR analysis. The findings reveal that 42.6% (128/300) of the strains exhibited resistance to at least one of the eight antibiotics assessed, and 18.6% (56/300) demonstrated multidrug resistance (MDR), that distributed across 69 distinct resistance patterns. Altogether 2.6% of E. coli strains (8/300) were confirmed as TEM and CTX-M type ESBL producers. These outcomes underscore the roles of dogs and cats in Tamaulipas as reservoirs for the dissemination of MDR and/or ESBL strains. The results underscore the necessity for conducting prevalence studies on ESBL-producing E. coli, forming a foundation for comprehending the present scenario and formulating strategies for the control and mitigation of this issue.","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":"95 1","pages":"228-236"},"PeriodicalIF":1.5,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142263751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and characteristics of ESBL-producing Salmonella in Weifang, China. 中国潍坊产 ESBL 沙门氏菌的流行情况和特征。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-09-03 Print Date: 2024-09-18 DOI: 10.1556/030.2024.02347
Xuesong Wang, Binglei Wang, Xiaohong Lu, Jie Ma, Zhanzhao Wang, Yuhui Wang

This study examined the prevalence and antibiotic resistance pattern of blaCTX-M extended-spectrum β-lactamase positive Salmonella species isolated from a hospital in Weifang. Salmonella strains were isolated from hospitalized patients from January 2018 to April 2023. Whole-genome sequencing was performed by Illumina platform. CTX-M-producing Salmonella were identified by Comprehensive Antibiotic Research Database (CARD). Strain susceptibility to six antimicrobial agents was assessed by BD Phoenix™ M50 System. MLST analysis confirmed sequence types and additionally, serotypes were determined by SeqSero2. Genetic environments of blaCTX-M genes were analyzed by Isfinder and BLASTn. Single nucleotide polymorphisms were used to construct a phylogenetic tree to analyze homology. A total of 34 CTX-M-producing Salmonella were detected. The most prevalent serotype was Salmonella enterica subsp. enterica 1,4,[5],12:i:- (14/34, 41.18%), belonging to ST34, followed by Salmonella Enteritidis (10/34, 29.41%), belonging to ST11. The highest resistance rate was detected to ampicillin (97.06%), followed by ceftriaxone (94.12%) and ceftazidime (58.83%). In CTX-M-producing Salmonella five types of blaCTX-M genes were identified, the most prevalent was blaCTX-M-55 (47.06%, 16/34), followed by blaCTX-M-14, blaCTX-M-65, blaCTX-M-125, and blaCTX-M-27 at 26.47% (9/34), 11.77% (4/34), 8.82% (3/34), and 5.88% (2/34), respectively. Apart from blaCTX-M, 40 antibiotic resistance genes were also detected, conveying resistance to multiple drugs and the most frequent genes were namely, mcr-1.1, aph(6)-Id, aph(3″)-Ib, oqxAB, qnrB6, qnrS1. According to genetic environment analysis, the insertion sequence ISEcp1 was prevalent upstream of the blaCTX-M gene. Our study demonstrates that multiple resistance genes are carried by clinical isolates of Salmonella spp. however, the dominant ESBL genotype is CTX-M-55, that is associated with ISEcp1.

本研究考察了从潍坊某医院分离出的 blaCTX-M 扩谱β-内酰胺酶阳性沙门氏菌的流行率和抗生素耐药模式。沙门氏菌菌株从2018年1月至2023年4月的住院患者中分离出来。采用Illumina平台进行全基因组测序。通过抗生素研究综合数据库(CARD)鉴定出产CTX-M的沙门氏菌。菌株对六种抗菌剂的敏感性由 BD Phoenix™ M50 系统进行评估。MLST 分析确认了序列类型,此外,SeqSero2 还确定了血清型。用 Isfinder 和 BLASTn 分析了 blaCTX-M 基因的遗传环境。利用单核苷酸多态性构建系统发生树,分析同源性。共检测到 34 个产 CTX-M 的沙门氏菌。最常见的血清型是肠炎沙门氏菌亚种 1,4,[5],12:i:-(14/34,41.18%),属于 ST34,其次是肠炎沙门氏菌(10/34,29.41%),属于 ST11。对氨苄西林的耐药率最高(97.06%),其次是头孢曲松(94.12%)和头孢他啶(58.83%)。在产CTX-M沙门氏菌中发现了5种类型的blaCTX-M基因,其中最常见的是blaCTX-M-55(47.06%,16/34),其次是blaCTX-M-14、blaCTX-M-65、blaCTX-M-125和blaCTX-M-27,分别占26.47%(9/34)、11.77%(4/34)、8.82%(3/34)和5.88%(2/34)。除 blaCTX-M 外,还检测到 40 个抗生素耐药基因,这些基因传递着对多种药物的耐药性,其中最常见的基因是 mcr-1.1、ahph(6)-Id、ahph(3″)-Ib、ocqxAB、qnrB6 和 qnrS1。根据遗传环境分析,插入序列 ISEcp1 普遍存在于 blaCTX-M 基因的上游。我们的研究表明,沙门氏菌属临床分离株携带多种抗性基因,但最主要的 ESBL 基因型是 CTX-M-55,这与 ISEcp1 有关。
{"title":"Prevalence and characteristics of ESBL-producing Salmonella in Weifang, China.","authors":"Xuesong Wang, Binglei Wang, Xiaohong Lu, Jie Ma, Zhanzhao Wang, Yuhui Wang","doi":"10.1556/030.2024.02347","DOIUrl":"10.1556/030.2024.02347","url":null,"abstract":"<p><p>This study examined the prevalence and antibiotic resistance pattern of blaCTX-M extended-spectrum β-lactamase positive Salmonella species isolated from a hospital in Weifang. Salmonella strains were isolated from hospitalized patients from January 2018 to April 2023. Whole-genome sequencing was performed by Illumina platform. CTX-M-producing Salmonella were identified by Comprehensive Antibiotic Research Database (CARD). Strain susceptibility to six antimicrobial agents was assessed by BD Phoenix™ M50 System. MLST analysis confirmed sequence types and additionally, serotypes were determined by SeqSero2. Genetic environments of blaCTX-M genes were analyzed by Isfinder and BLASTn. Single nucleotide polymorphisms were used to construct a phylogenetic tree to analyze homology. A total of 34 CTX-M-producing Salmonella were detected. The most prevalent serotype was Salmonella enterica subsp. enterica 1,4,[5],12:i:- (14/34, 41.18%), belonging to ST34, followed by Salmonella Enteritidis (10/34, 29.41%), belonging to ST11. The highest resistance rate was detected to ampicillin (97.06%), followed by ceftriaxone (94.12%) and ceftazidime (58.83%). In CTX-M-producing Salmonella five types of blaCTX-M genes were identified, the most prevalent was blaCTX-M-55 (47.06%, 16/34), followed by blaCTX-M-14, blaCTX-M-65, blaCTX-M-125, and blaCTX-M-27 at 26.47% (9/34), 11.77% (4/34), 8.82% (3/34), and 5.88% (2/34), respectively. Apart from blaCTX-M, 40 antibiotic resistance genes were also detected, conveying resistance to multiple drugs and the most frequent genes were namely, mcr-1.1, aph(6)-Id, aph(3″)-Ib, oqxAB, qnrB6, qnrS1. According to genetic environment analysis, the insertion sequence ISEcp1 was prevalent upstream of the blaCTX-M gene. Our study demonstrates that multiple resistance genes are carried by clinical isolates of Salmonella spp. however, the dominant ESBL genotype is CTX-M-55, that is associated with ISEcp1.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"220-227"},"PeriodicalIF":1.3,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142124505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outbreak caused by multidrug-resistant OXA-48 and NDM-1 producing Klebsiella pneumoniae in the intensive care unit of a cancer hospital. 一家癌症医院重症监护室爆发由产生耐多药 OXA-48 和 NDM-1 的肺炎克雷伯菌引起的疫情。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-29 Print Date: 2024-09-18 DOI: 10.1556/030.2024.02364
Serap Süzük Yıldız, Esra Tavukcu, Sevgi Şahin, Gülşen İskender, Özlem Ünaldı, Buket Demirhan, Zuhal Avşar, Elif Özgür Orman, İpek Mumcuoğlu, Tuba Dal

We report a nosocomial outbreak caused by a multidrug-resistant carbapenemase-producing Klebsiella pneumoniae (MDRCPKp), that was detected in six patients admitted to the medical intensive care unit between 20th of December 2023 and 15th of January 2024 in Ankara, Turkey. The investigation of this outbreak was started on 29th of December 2023. During the outbreak 11 samples were collected from the six patients with MDRCPKp. Pulsed-field gel electrophoresis (PFGE) was performed to determine the genetic relatedness and clonality of MDRCPKp strains. MDRCPKp was isolated in the tracheal aspiration culture, blood, urine, and screening samples. Five patients with MDRCPKp colonization developed healthcare-associated infection. In one patient MDRCPKp was isolated from tracheal aspirate and the screening cultures were considered as colonization not infection. PFGE analysis revealed that all isolates belonged to the same K. pneumoniae clone. MDRCPKp strain of this outbreak exhibited multidrug resistance and co-produced OXA-48 and NDM-1. This outbreak ended after application of strict infection control measures. An outbreak of MDRCPKp can occur in hospitals, especially in the intensive care units; thus, it should be detected early by infection control teams. A strong collaboration between infection control team and microbiology laboratory is essential to cope with MDR bacterial outbreaks in hospitals.

我们报告了 2023 年 12 月 20 日至 2024 年 1 月 15 日期间在土耳其安卡拉医疗重症监护室收治的六名患者中发现的由产多种耐药碳青霉烯酶肺炎克雷伯氏菌(MDRCPKp)引起的院内疫情。疫情调查始于 2023 年 12 月 29 日。疫情爆发期间,从六名 MDRCPKp 患者身上采集了 11 份样本。进行了脉冲场凝胶电泳(PFGE)以确定 MDRCPKp 菌株的遗传亲缘关系和克隆性。在气管抽吸培养物、血液、尿液和筛查样本中分离出了 MDRCPKp。五名有 MDRCPKp 定植的患者出现了医源性感染。一名患者从气管吸出物中分离出了 MDRCPKp,筛查培养结果被认为是定植而非感染。PFGE 分析显示,所有分离株都属于同一个肺炎克隆。此次疫情中的 MDRCPKp 菌株表现出多药耐药性,并可联合产生 OXA-48 和 NDM-1。在采取严格的感染控制措施后,疫情结束。MDRCPKp 可在医院爆发,尤其是在重症监护室;因此,感染控制小组应及早发现。感染控制小组与微生物实验室之间的紧密合作对于应对医院中 MDR 细菌的爆发至关重要。
{"title":"Outbreak caused by multidrug-resistant OXA-48 and NDM-1 producing Klebsiella pneumoniae in the intensive care unit of a cancer hospital.","authors":"Serap Süzük Yıldız, Esra Tavukcu, Sevgi Şahin, Gülşen İskender, Özlem Ünaldı, Buket Demirhan, Zuhal Avşar, Elif Özgür Orman, İpek Mumcuoğlu, Tuba Dal","doi":"10.1556/030.2024.02364","DOIUrl":"10.1556/030.2024.02364","url":null,"abstract":"<p><p>We report a nosocomial outbreak caused by a multidrug-resistant carbapenemase-producing Klebsiella pneumoniae (MDRCPKp), that was detected in six patients admitted to the medical intensive care unit between 20th of December 2023 and 15th of January 2024 in Ankara, Turkey. The investigation of this outbreak was started on 29th of December 2023. During the outbreak 11 samples were collected from the six patients with MDRCPKp. Pulsed-field gel electrophoresis (PFGE) was performed to determine the genetic relatedness and clonality of MDRCPKp strains. MDRCPKp was isolated in the tracheal aspiration culture, blood, urine, and screening samples. Five patients with MDRCPKp colonization developed healthcare-associated infection. In one patient MDRCPKp was isolated from tracheal aspirate and the screening cultures were considered as colonization not infection. PFGE analysis revealed that all isolates belonged to the same K. pneumoniae clone. MDRCPKp strain of this outbreak exhibited multidrug resistance and co-produced OXA-48 and NDM-1. This outbreak ended after application of strict infection control measures. An outbreak of MDRCPKp can occur in hospitals, especially in the intensive care units; thus, it should be detected early by infection control teams. A strong collaboration between infection control team and microbiology laboratory is essential to cope with MDR bacterial outbreaks in hospitals.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"206-210"},"PeriodicalIF":1.3,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ESKAPE pathogens in pediatric cardiac surgery patients: 5-year microbiological monitoring in a tertiary hospital in Kazakhstan. 小儿心脏手术患者中的 ESKAPE 病原体:哈萨克斯坦一家三级医院的 5 年微生物监测。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-27 Print Date: 2024-09-18 DOI: 10.1556/030.2024.02352
Abay Baigenzhin, Nelya Bissenova, Aigerim Yergaliyeva, Shukhrat Marassulov, Elmira Tuleubayeva, Ulzhan Aitysheva

Hospital acquired infections greatly affect recovery and survival in pediatric surgical patients. We evaluated prevalence and antimicrobial resistance of ESKAPE pathogens in neonates and infants subjected to cardiac surgery in a tertiary hospital in Central Kazakhstan between 2019 and 2023 (2,278 patients) using routine methods of microbiological detection. ESKAPE pathogens were found in 1,899 out of 2,957 samples (Staphylococcus aureus - 35.3%, Klebsiella pneumoniae - 27.8%, Acinetobacter baumannii - 14.5%, Pseudomonas aeruginosa - 12.4%, Enterobacter sp. - 8.8%, Enterococcus faecium - 1.2%). The total prevalence of ESKAPE increased significantly from 45.1 to 76.9% (P = 0.005) during the study period. The resistance significantly increased in methicillin-resistant S. aureus (MRSA, from 13.7 to 41.9%, P = 0.041) but decreased in carbapenem-resistant P. aeruginosa (from 64.3 to 37.7%, P = 0.037) and carbapenem-resistant A. baumannii (from 48.5 to 19.1%, P = 0.039). Gradual but non-significant changes were shown in third-generation cephalosporin resistant K. pneumoniae (from 63.6 to 45.2%) and carbapenem-resistant K. pneumoniae (from 0 to 8.3%). The relative prevalence of ESKAPE pathogens steadily increased in our pediatric cardiac surgery patients in 2019-2023. The most frequent were S. aureus, K. pneumoniae, and A. baumannii, with dramatically increasing tendencies for MRSA. Our results highlight the necessity for a well-designed infection control strategy and constant microbiological monitoring in pediatric cardiac surgery departments.

医院感染极大地影响了儿科手术患者的康复和存活。我们采用常规微生物检测方法,评估了2019年至2023年期间在哈萨克斯坦中部一家三甲医院接受心脏手术的新生儿和婴儿(2278名患者)中ESKAPE病原体的流行率和抗菌药耐药性。在 2957 份样本中,有 1899 份样本发现了 ESKAPE 病原体(金黄色葡萄球菌 - 35.3%,肺炎克雷伯菌 - 27.8%,鲍曼不动杆菌 - 14.5%,铜绿假单胞菌 - 12.4%,肠杆菌 - 8.8%,粪肠球菌 - 1.2%)。在研究期间,ESKAPE 的总流行率从 45.1% 显著上升至 76.9%(P = 0.005)。耐甲氧西林金黄色葡萄球菌(MRSA,从 13.7% 增至 41.9%,P = 0.041)的耐药性明显增加,但耐碳青霉烯铜绿假单胞菌(从 64.3% 降至 37.7%,P = 0.037)和耐碳青霉烯鲍曼不动杆菌(从 48.5% 降至 19.1%,P = 0.039)的耐药性则有所下降。对第三代头孢菌素耐药的肺炎双球菌(从 63.6% 降至 45.2%)和对碳青霉烯耐药的肺炎双球菌(从 0% 降至 8.3%)出现了渐进但不显著的变化。2019-2023年,我院小儿心脏手术患者中ESKAPE病原体的相对流行率稳步上升。最常见的病原体是金黄色葡萄球菌、肺炎双球菌和鲍曼不动杆菌,MRSA的发病率也呈急剧上升趋势。我们的研究结果凸显了在小儿心脏手术科室实施精心设计的感染控制策略和持续微生物监测的必要性。
{"title":"ESKAPE pathogens in pediatric cardiac surgery patients: 5-year microbiological monitoring in a tertiary hospital in Kazakhstan.","authors":"Abay Baigenzhin, Nelya Bissenova, Aigerim Yergaliyeva, Shukhrat Marassulov, Elmira Tuleubayeva, Ulzhan Aitysheva","doi":"10.1556/030.2024.02352","DOIUrl":"10.1556/030.2024.02352","url":null,"abstract":"<p><p>Hospital acquired infections greatly affect recovery and survival in pediatric surgical patients. We evaluated prevalence and antimicrobial resistance of ESKAPE pathogens in neonates and infants subjected to cardiac surgery in a tertiary hospital in Central Kazakhstan between 2019 and 2023 (2,278 patients) using routine methods of microbiological detection. ESKAPE pathogens were found in 1,899 out of 2,957 samples (Staphylococcus aureus - 35.3%, Klebsiella pneumoniae - 27.8%, Acinetobacter baumannii - 14.5%, Pseudomonas aeruginosa - 12.4%, Enterobacter sp. - 8.8%, Enterococcus faecium - 1.2%). The total prevalence of ESKAPE increased significantly from 45.1 to 76.9% (P = 0.005) during the study period. The resistance significantly increased in methicillin-resistant S. aureus (MRSA, from 13.7 to 41.9%, P = 0.041) but decreased in carbapenem-resistant P. aeruginosa (from 64.3 to 37.7%, P = 0.037) and carbapenem-resistant A. baumannii (from 48.5 to 19.1%, P = 0.039). Gradual but non-significant changes were shown in third-generation cephalosporin resistant K. pneumoniae (from 63.6 to 45.2%) and carbapenem-resistant K. pneumoniae (from 0 to 8.3%). The relative prevalence of ESKAPE pathogens steadily increased in our pediatric cardiac surgery patients in 2019-2023. The most frequent were S. aureus, K. pneumoniae, and A. baumannii, with dramatically increasing tendencies for MRSA. Our results highlight the necessity for a well-designed infection control strategy and constant microbiological monitoring in pediatric cardiac surgery departments.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"211-219"},"PeriodicalIF":1.3,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report of an abdominal wet gangrene caused by Acidaminococcus. 由酸性球菌引起的腹部湿性坏疽病例报告。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-26 Print Date: 2024-09-18 DOI: 10.1556/030.2024.02332
Ahmed Fakhfakh, Sana Ferjani, Lamia Kanzari, Asma Ferjani, Zaineb Hamzaoui, Amel Rehaiem, Anis Ben Dhaou, Montassar Aloui, Yasser Karoui, Noura Syala, Hedia Bouaani, Mounir Ben Moussa, Ilhem Boutiba Ben Boubaker

The Acidaminococcus genus is a part of the normal flora in gastrointestinal tract. It is a strictly anaerob Gram-negative coccus that is rarely pathogenic. We report the case of a 58-year-old man, who presented to surgery department A of the Charles Nicolle hospital, complaining of a wide inflammatory lesion in the anterior abdominal wall evolving for two weeks. Patient's anamnestic data included smoking, hypertension, and diabetes mellitus with poor compliance. The patient underwent flattening with excision of necrotic tissues and surgical drainage using a DELBET blade. Empirical antibiotic therapy with imipenem 1gx3/d, teicoplanin 400 mg 1 inj x2/d and gentamicin 400 mg 1 inj/d was administered pending bacteriological results. The bacteriological examination of a sample of necrotic tissue, after 72 h of incubation at 37 °C in anaerobic atmosphere, was able to detect a Gram-negative coccus, that the VITEK2 ANC system identified as Actinomyces canis with an accuracy of 80%. Whole genome sequencing was subsequently performed, that identified Acidaminococcus sp. AM33-14BH and demonstrated the following resistance genes: cfxa, tet(X) and tet(Q). An antibiogram for anaerobes was performed showing that the strain was resistant to amoxicillin but sensitive to amoxicillin-clavulanic acid, piperacillin-tazobactam, ertapenem, imipenem, meropenem and rifampin. Patient's condition improved after treatment with imipenem for 2 weeks, followed by oral amoxicillin-clavulanic acid for 16 days.This work highlights the role of molecular biology in the diagnosis of infections caused by anaerobes. Although the Vitek 2 ANC card provides rapid and acceptable identification of the most common anaerobic bacteria, improvements are needed for the identification of bacteria in the genera Acidaminococcus and Actinomyces.

酸性球菌属是胃肠道正常菌群的一部分。它是一种严格厌氧的革兰氏阴性球菌,很少致病。我们报告了一例 58 岁男子的病例,他来到查尔斯-尼科尔医院外科 A 区就诊,主诉腹壁前部出现广泛炎性病变,已持续两周。患者的病史包括吸烟、高血压和糖尿病,且依从性较差。患者接受了扁平化手术,切除了坏死组织,并使用 DELBET 刀片进行了手术引流。在细菌学检查结果出来之前,患者接受了亚胺培南 1gx3/d 、替考拉宁 400 mg 1 inj x2/d 和庆大霉素 400 mg 1 inj/d 的经验性抗生素治疗。对坏死组织样本进行细菌学检查,在厌氧环境中于 37 °C 培养 72 小时后,检测出一种革兰氏阴性球菌,VITEK2 ANC 系统将其鉴定为犬放线菌,准确率达 80%。随后进行了全基因组测序,确定了 Acidaminococcus sp. AM33-14BH,并显示了以下抗性基因:Cfxa、tet(X) 和 tet(Q)。厌氧菌抗生素图显示,该菌株对阿莫西林耐药,但对阿莫西林-克拉维酸、哌拉西林-他唑巴坦、厄他培南、亚胺培南、美罗培南和利福平敏感。亚胺培南治疗 2 周后,患者病情有所好转,随后又口服阿莫西林-克拉维酸 16 天。尽管 Vitek 2 ANC 卡能快速鉴定最常见的厌氧菌,但在鉴定酸性球菌属和放线菌属细菌方面还需要改进。
{"title":"Case report of an abdominal wet gangrene caused by Acidaminococcus.","authors":"Ahmed Fakhfakh, Sana Ferjani, Lamia Kanzari, Asma Ferjani, Zaineb Hamzaoui, Amel Rehaiem, Anis Ben Dhaou, Montassar Aloui, Yasser Karoui, Noura Syala, Hedia Bouaani, Mounir Ben Moussa, Ilhem Boutiba Ben Boubaker","doi":"10.1556/030.2024.02332","DOIUrl":"10.1556/030.2024.02332","url":null,"abstract":"<p><p>The Acidaminococcus genus is a part of the normal flora in gastrointestinal tract. It is a strictly anaerob Gram-negative coccus that is rarely pathogenic. We report the case of a 58-year-old man, who presented to surgery department A of the Charles Nicolle hospital, complaining of a wide inflammatory lesion in the anterior abdominal wall evolving for two weeks. Patient's anamnestic data included smoking, hypertension, and diabetes mellitus with poor compliance. The patient underwent flattening with excision of necrotic tissues and surgical drainage using a DELBET blade. Empirical antibiotic therapy with imipenem 1gx3/d, teicoplanin 400 mg 1 inj x2/d and gentamicin 400 mg 1 inj/d was administered pending bacteriological results. The bacteriological examination of a sample of necrotic tissue, after 72 h of incubation at 37 °C in anaerobic atmosphere, was able to detect a Gram-negative coccus, that the VITEK2 ANC system identified as Actinomyces canis with an accuracy of 80%. Whole genome sequencing was subsequently performed, that identified Acidaminococcus sp. AM33-14BH and demonstrated the following resistance genes: cfxa, tet(X) and tet(Q). An antibiogram for anaerobes was performed showing that the strain was resistant to amoxicillin but sensitive to amoxicillin-clavulanic acid, piperacillin-tazobactam, ertapenem, imipenem, meropenem and rifampin. Patient's condition improved after treatment with imipenem for 2 weeks, followed by oral amoxicillin-clavulanic acid for 16 days.This work highlights the role of molecular biology in the diagnosis of infections caused by anaerobes. Although the Vitek 2 ANC card provides rapid and acceptable identification of the most common anaerobic bacteria, improvements are needed for the identification of bacteria in the genera Acidaminococcus and Actinomyces.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"248-252"},"PeriodicalIF":1.3,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142071728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic characterization of an uncommon Delftia acidovorans isolate obtained from a Bulgarian immunocompetent outpatient diagnosed with bronchitis. 从保加利亚一名被诊断为支气管炎的免疫功能正常的门诊病人身上分离出的一种不常见的 Delftia acidovorans 的基因组特征。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-08-26 Print Date: 2024-09-18 DOI: 10.1556/030.2024.02331
Slavil Peykov, Raina Gergova, Svetlana Atanasova, Svetoslav G Dimov, Tanya Strateva

Delftia acidovorans is an aerobic, non-fermenting Gram-negative bacterium (NFGNB), found in soil, water and hospital environments. It is rarely clinically significant, most commonly affecting hospitalized or immunocompromised patients. The present study aimed to explore the genomic characteristics of a Bulgarian clinical D. acidovorans isolate (designated Dac759) in comparison to all strains of this species with available genomes in the NCBI Genome database (n = 34). Dac759 was obtained in 2021 from the sputum of a 65-year-old female immunocompetent outpatient with bronchitis. Species identification using MALDI-TOF mass spectrometry, antimicrobial susceptibility testing, whole-genome sequencing (WGS), and phylogenomic analysis were performed. The isolate demonstrated high-level resistance to colistin (16 mg L-1); resistance to gentamicin; reduced susceptibility to piperacillin, piperacillin-tazobactam, ceftazidime, cefepime, ciprofloxacin, and levofloxacin; and susceptibility to imipenem, meropenem, amikacin, and tobramycin. The observed genome size (6.43 Mb) and GC content (66.76%) were comparable with the accessible data from sequenced D. acidovorans genomes. A limited number of resistance determinants were identified in the assembled genome as follows: blaOXA-459, emrE, oqxB, and mexCD-oprJ. The phylogenomic analysis indicated a high heterogenicity of the included D. acidovorans genomes. In conclusion, to the best of our knowledge, this is the first documented case of a clinically relevant D. acidovorans isolate in Bulgaria. Unlike the majority of reports in the literature, Dac759 affected a patient with no malignancies or other preexisting comorbidities. With this in mind, its genome sequence is a valuable resource for the fundamental study of uncommon bacterial pathogens of public health importance.

Delftia acidovorans 是一种需氧、非发酵革兰氏阴性细菌(NFGNB),存在于土壤、水和医院环境中。它很少有临床意义,最常见于住院病人或免疫力低下的病人。本研究旨在探索保加利亚临床 D. acidovorans 分离物(命名为 Dac759)的基因组特征,并将其与 NCBI 基因组数据库(n = 34)中有基因组的所有菌株进行比较。Dac759 于 2021 年从一名 65 岁的女性支气管炎门诊患者的痰中获得。研究人员利用 MALDI-TOF 质谱进行了菌种鉴定,并进行了抗菌药敏感性测试、全基因组测序(WGS)和系统发生组分析。该分离株对可乐定(16 mg L-1)表现出高度耐药性;对庆大霉素表现出耐药性;对哌拉西林、哌拉西林-他唑巴坦、头孢他啶、头孢吡肟、环丙沙星和左氧氟沙星的敏感性降低;对亚胺培南、美罗培南、阿米卡星和妥布霉素表现出敏感性。观察到的基因组大小(6.43 Mb)和 GC 含量(66.76%)与可从已测序的 D. acidovorans 基因组获得的数据相当。在组装的基因组中发现了少量抗性决定因子:blaOXA-459、emrE、ocxB 和 mexCD-oprJ。系统发生组分析表明,所包含的 D. acidovorans 基因组具有高度异源性。总之,据我们所知,这是保加利亚第一例与临床相关的 D. acidovorans 分离物。与大多数文献报道不同的是,Dac759 感染的患者没有恶性肿瘤或其他原有合并症。有鉴于此,它的基因组序列是对具有公共卫生重要性的不常见细菌病原体进行基础研究的宝贵资源。
{"title":"Genomic characterization of an uncommon Delftia acidovorans isolate obtained from a Bulgarian immunocompetent outpatient diagnosed with bronchitis.","authors":"Slavil Peykov, Raina Gergova, Svetlana Atanasova, Svetoslav G Dimov, Tanya Strateva","doi":"10.1556/030.2024.02331","DOIUrl":"10.1556/030.2024.02331","url":null,"abstract":"<p><p>Delftia acidovorans is an aerobic, non-fermenting Gram-negative bacterium (NFGNB), found in soil, water and hospital environments. It is rarely clinically significant, most commonly affecting hospitalized or immunocompromised patients. The present study aimed to explore the genomic characteristics of a Bulgarian clinical D. acidovorans isolate (designated Dac759) in comparison to all strains of this species with available genomes in the NCBI Genome database (n = 34). Dac759 was obtained in 2021 from the sputum of a 65-year-old female immunocompetent outpatient with bronchitis. Species identification using MALDI-TOF mass spectrometry, antimicrobial susceptibility testing, whole-genome sequencing (WGS), and phylogenomic analysis were performed. The isolate demonstrated high-level resistance to colistin (16 mg L-1); resistance to gentamicin; reduced susceptibility to piperacillin, piperacillin-tazobactam, ceftazidime, cefepime, ciprofloxacin, and levofloxacin; and susceptibility to imipenem, meropenem, amikacin, and tobramycin. The observed genome size (6.43 Mb) and GC content (66.76%) were comparable with the accessible data from sequenced D. acidovorans genomes. A limited number of resistance determinants were identified in the assembled genome as follows: blaOXA-459, emrE, oqxB, and mexCD-oprJ. The phylogenomic analysis indicated a high heterogenicity of the included D. acidovorans genomes. In conclusion, to the best of our knowledge, this is the first documented case of a clinically relevant D. acidovorans isolate in Bulgaria. Unlike the majority of reports in the literature, Dac759 affected a patient with no malignancies or other preexisting comorbidities. With this in mind, its genome sequence is a valuable resource for the fundamental study of uncommon bacterial pathogens of public health importance.</p>","PeriodicalId":7119,"journal":{"name":"Acta microbiologica et immunologica Hungarica","volume":" ","pages":"242-247"},"PeriodicalIF":1.3,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142071729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta microbiologica et immunologica Hungarica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1